Xencor (NASDAQ: XNCR) net income
Xencor reported a net loss of $91.9m for fiscal 2025; in fiscal 2024 it reported a net loss of $232.6m. Earnings per share were −$1.24.
Xencor's best year of the last 10 was fiscal 2021. It reported a loss in 7 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$91.9m | — | −73.2% | −$1.24 |
| 2024 | −$232.6m | — | −210.5% | −$3.58 |
| 2023 | −$133.1m | — | −76.2% | −$2.20 |
| 2022 | −$55.2m | −166.8% | −33.5% | −$0.93 |
| 2021 | $82.6m | — | 30.0% | $1.42 |
| 2020 | −$69.3m | −358.0% | −56.5% | −$1.21 |
| 2019 | $26.9m | — | 17.2% | $0.48 |
| 2018 | −$70.4m | — | −173.4% | −$1.31 |
| 2017 | −$38.5m | −185.3% | −83.4% | −$0.82 |
| 2016 | $45.1m | — | 41.4% | $1.09 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Xencor net income compared with its sector
By net income for its latest fiscal year, Xencor ranks 328th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Xencor, −73.2%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 326th | Altimmune | −$88.1m | −214,861.0% |
| 327th | Neurogene | −$90.4m | — |
| 328th | Xencor | −$91.9m | −73.2% |
| 329th | Orthofix Medical | −$92.2m | −11.2% |
| 330th | PROCEPT BioRobotics | −$95.6m | −31.0% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Xencor
- How much did Xencor earn in fiscal 2025?
- Xencor reported a net loss of $91.9m for fiscal 2025. In fiscal 2024 it reported a net loss of $232.6m.
- What are the earnings per share of Xencor?
- They were −$1.24 in fiscal 2025, compared with −$3.58 in fiscal 2024.
- What was the most profitable year for Xencor?
- Of its last 10 fiscal years, fiscal 2021, with $82.6m.
- Where does Xencor rank in its sector by net income?
- It ranks 328th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Xencor come from?
- From the annual report (Form 10-K) that Xencor files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Xencor files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Xencor: the Xencor page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.